Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells

被引:0
|
作者
Rhonda L Taylor
Mark N Cruickshank
Mahdad Karimi
Han Leng Ng
Elizabeth Quail
Kenneth M Kaufman
John B Harley
Lawrence J Abraham
Betty P Tsao
Susan A Boackle
Daniela Ulgiati
机构
[1] School of Pathology and Laboratory Medicine,Division of Rheumatology, Department of Medicine
[2] Centre for Genetic Origins of Health and Disease,Division of Rheumatology
[3] The University of Western Australia,undefined
[4] Biochemistry and Molecular Biology,undefined
[5] School of Chemistry and Biochemistry,undefined
[6] The University of Western Australia,undefined
[7] Telethon Kids Institute,undefined
[8] The University of Western Australia,undefined
[9] Cincinnati Children's Hospital Medical Center,undefined
[10] US Department of Veterans Affairs Medical Center,undefined
[11] University of California at Los Angeles,undefined
[12] University of Colorado School of Medicine,undefined
[13] Aurora,undefined
[14] CO,undefined
[15] USA,undefined
来源
关键词
B cells; core promoter; CR2/CD21; molecular biology; transcription factor;
D O I
暂无
中图分类号
学科分类号
摘要
Complement receptor 2 (CR2/CD21) is predominantly expressed on the surface of mature B cells where it forms part of a coreceptor complex that functions, in part, to modulate B-cell receptor signal strength. CR2/CD21 expression is tightly regulated throughout B-cell development such that CR2/CD21 cannot be detected on pre-B or terminally differentiated plasma cells. CR2/CD21 expression is upregulated at B-cell maturation and can be induced by IL-4 and CD40 signaling pathways. We have previously characterized elements in the proximal promoter and first intron of CR2/CD21 that are involved in regulating basal and tissue-specific expression. We now extend these analyses to the CR2/CD21 core promoter. We show that in mature B cells, CR2/CD21 transcription proceeds from a focused TSS regulated by a non-consensus TATA box, an initiator element and a downstream promoter element. Furthermore, occupancy of the general transcriptional machinery in pre-B versus mature B-cell lines correlate with CR2/CD21 expression level and indicate that promoter accessibility must switch from inactive to active during the transitional B-cell window.
引用
收藏
页码:119 / 131
页数:12
相关论文
共 49 条
  • [1] Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells
    Taylor, Rhonda L.
    Cruickshank, Mark N.
    Karimi, Mahdad
    Ng, Han Leng
    Quail, Elizabeth
    Kaufman, Kenneth M.
    Harley, John B.
    Abraham, Lawrence J.
    Tsao, Betty P.
    Boackle, Susan A.
    Ulgiati, Daniela
    CELLULAR & MOLECULAR IMMUNOLOGY, 2016, 13 (01) : 119 - 131
  • [2] CR2/CD21 proximal promoter activity is critically dependent on a cell type-specific repressor
    Ulgiati, D
    Holers, VM
    JOURNAL OF IMMUNOLOGY, 2001, 167 (12): : 6912 - 6919
  • [3] C3 regulates expression of human complement receptor 2 (CR2, CD21) on mouse B cells
    Marchbank, KJ
    Kulik, L
    Birrell, L
    Haluzcszak, C
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 272 - 272
  • [4] Functional analysis of the human complement receptor 2 (CR2/CD21) promoter: Characterization of basal transcriptional mechanisms
    Ulgiati, D
    Pham, C
    Holers, VM
    JOURNAL OF IMMUNOLOGY, 2002, 168 (12): : 6279 - 6285
  • [5] Distribution of the chromatin protein DEK distinguishes active and inactive CD21/CR2 gene in pre- and mature B lymphocytes
    Hu, HG
    Illges, H
    Gruss, C
    Knippers, R
    INTERNATIONAL IMMUNOLOGY, 2005, 17 (06) : 789 - 796
  • [6] Pathways controlling the expression of surface CD21 (CR2) and CD23 (Fc(epsilon)IIR) proteins in human malignant B cells
    Shubinsky, G
    Schlesinger, M
    Polliack, A
    Rabinowitz, R
    LEUKEMIA & LYMPHOMA, 1997, 25 (5-6) : 521 - 530
  • [7] Complement receptor CR2/CD21 proximal promoter activity is critically dependent upon a cell type specific repressor.
    Ulgiati, D
    Holers, VM
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S203 - S203
  • [8] Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development
    Kulik, Liudmila
    Marchbank, Kevin J.
    Lyubchenko, Taras
    Kuhn, Kristine A.
    Liubchenko, Ganna A.
    Haluszczak, Catherine
    Gibson, Matthew G.
    Boackle, Susan A.
    Holers, V. Michael
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (03) : 623 - 633
  • [9] Tandem E box motifs control complement receptor 2 (CR2/CD21) promoter activity via a novel repressor protein and chromatin accessibility
    Cruikshank, Mark N.
    Fenwick, Emily J.
    Dods, James
    Holers, V. Michael
    Abraham, Lawrence J.
    Ulgiati, Daniela
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 162 - 162
  • [10] Changes in chromatin accessibility across the complement receptor 2 (CR2/CD21) gene promoter occurs during different stages of B cell development
    Cruikshank, Mark N.
    Fenwick, Emily J.
    Abraham, Lawrence J.
    Ulgiati, Daniela
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 162 - 162